IRIS

PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome / Sollini, M; Di Tommaso, L; Kirienko, M; Piombo, C; Erreni, M; Lania, Ag; Antunovic, L; Chiti, A. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 46:SUPPL 1(2019), pp. 704-704. ( 32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) Barcelona, SPAIN OCT 12-16, 2019).

PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome

Sollini M;Chiti A
Ultimo
2019-01-01
2019
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)
OCT 12-16, 2019
Barcelona, SPAIN
46
SUPPL 1
704
704
1
WOS:000492444406143
Sì
Internazionale
Goal 3: Good health and well-being
8
info:eu-repo/semantics/conferenceObject
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome / Sollini, M; Di Tommaso, L; Kirienko, M; Piombo, C; Erreni, M; Lania, Ag; Antunovic, L; Chiti, A. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 46:SUPPL 1(2019), pp. 704-704. ( 32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) Barcelona, SPAIN OCT 12-16, 2019).
none
274
4 Contributo in Atti di Convegno (Proceeding)::4.2 Abstract in Atti di convegno
Sollini, M; Di Tommaso, L; Kirienko, M; Piombo, C; Erreni, M; Lania, Ag; Antunovic, L; Chiti, A
4.2 Abstract in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/140781
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact